Chronic cerebrospinal venous insufficiency and menière's disease: Interventional versus medical therapy.
Menière disease
blood circulation
ecography
hypertension
inner ear
vertigo
Journal
The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
22
04
2019
revised:
20
08
2019
accepted:
15
10
2019
pubmed:
12
11
2019
medline:
30
10
2020
entrez:
12
11
2019
Statut:
ppublish
Résumé
To evaluate the incidence of chronic cerebrospinal venous insufficiency in Menière's disease patients and the effect of bilateral percutaneous transluminal angioplasty of the jugular/azygos veins compared to medical therapy. Prospective case-control study. Five hundred fourteen subjects were included in the study, 412 affected by definite Menière's disease, and 102 healthy controls. All patients underwent audiovestibular and vascular examination. Patients with Menière's disease and concomitant cerebrospinal venous insufficiency were divided in two subgroups: patients who underwent vascular intervention with bilateral percutaneous transluminal angioplasty (PTA) of the jugular/azygos veins and patients treated with medical therapy. Chronic cerebrospinal venous insufficiency was diagnosed in 330/412 (80.1%) Menière's disease patients and in 12/102 healthy individuals (11.8%) (P < .001). In the two chronic cerebrospinal venous insufficiency subgroups, a significant difference in Dizziness Handicap Inventory scores was found between patients in the PTA group compared to patients treated with medical therapy (31 ± 8.6 vs. 48.1 ± 14.4; P < .001); no significant differences were found for the Tinnitus Handicap Inventory scores (50.8 ± 16.58 vs. 49.6 ± 17.5; P = .23). Subjective evaluation of aural fullness was significantly better in patients in the PTA group (P = .003) as well as pure-tone average, which was significantly different between groups (49.8 ± 16.5 dB in the PTA group vs. 55.8 ± 13 in the medical therapy group; P = .035). The results of the present study confirm the close relationship between vascular disorders and Menière's disease. The encouraging responses to vascular interventional therapy on Meniére's disease symptoms suggest that this may be a promising path for interpretation and treatment of this complex disease. 2b Laryngoscope, 130: 2040-2046, 2020.
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2040-2046Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Informations de copyright
© 2019 The American Laryngological, Rhinological and Otological Society, Inc.
Références
Ménière P. Pathologie auriculaire: mémoires sur des lésions de l'oreille interne donnant lieu à des syptoms de congestion cérébrale apoplectiforme. Gaz Med Paris 1861;16:597-601.
Lopez-Escamez JA, Carey J, Chung W-H, Joel A. et al. Diagnostic criteria for Menière's disease. J Vestib Res 2015;25:1-7.
Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:181-185.
Louza J, Krause E, Gürkov R. Hearing function after intratympanic application of gadolinium-based contrast agent: a long-term evaluation. Laryngoscope 2015;125:2366-2370.
Casselman JW, Kuhweide R, Ampe W, Meeus L, Steyaert L. Pathology of the membranous labyrinth: comparison of T1- and T2-weighted and gadolinium-enhanced spin-echo and 3DFTCISS imaging. AJNR Am J Neuroradiol 1993;14:59-69.
Albers FW, Van Weissenbruch R, Casselman JW. 3DFT-magnetic resonance imaging of the inner ear in Ménière's disease. Acta Otolaryngol 1994;114:595-600.
Nakashima T, Naganawa S, Sugiura M, et al. Visualization of endolymphatic hydrops in patients with Ménière's disease. Laryngoscope 2007;117:415-420.
Naganawa S, Sugiura M, Kawamura M, Fukatsu H, Sone M, Nakashima T. Imaging of endolymphatic and perilymphatic fluid at 3T after intratympanic administration of gadolinium-diethylene-triamine pentaacetic acid. AJNR Am J Neuroradiol 2008;29:724-726.
Wu Q, Dai C, Zhao M, Sha Y. The correlation between symptoms of definite Meniere's disease and endolymphatic hydrops visualized by magnetic resonance imaging. Laryngoscope 2016;126:974-979.
Schuknecht HF, Gulya AJ. Endolymphatic hydrops-an overview and classification. Ann Otol Rhinol Laryngol 1983;92:1-20.
Sperling NM, Paparella MM, Yoon TH, Zelterman D. Symptomatic versus asymptomatic endolymphatic hydrops: a histopathologic comparison. Laryngoscope 1993;103:277-285.
Kiang NYS. An auditory physiologist's view of Ménière's syndrome. In: Nadol JB Jr, ed. Second International Symposium on Ménière's Disease. Amsterdam, the Netherlands: Kugler and Ghedini; 1989:13-24.
Nadol JB Jr, ed. Second International Symposium on Ménière's Disease. Amsterdam, the Netherlands: Kugler and Ghedini; 1989.
Ohmen JD, White CH, Li X, et al. Genetic evidence for an ethnic diversity in the susceptibility to Ménière's disease. Otol Neurotol 2013;34:1336-1341.
Belinchon A, Perez-Garrigues H, Tenias JM. Evolution of symptoms in Ménière's disease. Audiol Neurootol 2012;17:126-132.
Seo T, Saka N, Sakagami M. Furosemide-loading vestibular evoked myogenic potential testing can suggest developing bilateral involvement of unilateral Meniere's disease. Acta Otolaryngol 2012;132:632-636.
Friberg U, Stahle J, Svedberg A. The natural course of the Ménière's disease. Acta Otolaryngol Suppl 1984;406:72-77.
Havia M, Kentala E. Progression of symptoms of dizziness in Ménière's disease. Arch Otolaryngol Head Neck Surg 2004;130:431-435.
Tokumasu K, Fujino A, Yoshio S, Hoshino I. Prognosis of Ménière's disease by conservative treatment: retrospective study on the time course of the disease. Acta Otolaryngol Suppl 1995;519:216-218.
Liu YF, Renk E, Rauch SD, Xu HX. Efficacy of intratympanic gentamicin in Menière's disease with and without migraine. Otol Neurotol 2017;38:1005-1009.
Russo FY, Nguyen Y, De Seta D, et al. Meniett device in Meniere disease: randomized, double-blind, placebo-controlled multicenter trial. Laryngoscope 2017;12:470-475.
Syed MI, Ilan O, Leong AC, Pothier DD, Rutka JA. Menière's syndrome or disease: time trends in management and quality of evidence over the last two decades. Otol Neurotol 2015;36:1309-1316.
Russo FY, De Seta D, Lahlou G, et al. Fluctuating hearing loss in the only hearing ear: cochlear implantation in the contralateral deaf side. Otolaryngol Head Neck Surg 2018;158:1101-1106.
Pullens B, Verschuur HP, van Benthem PP. Surgery for Ménière's disease. Cochrane Database Syst Rev 2013;(2):CD005395.
Paparella MM. Endaural labyrinthectomy. Ear Nose Throat J 2008;87:204.
Li CS, Lai JT. Evaluation of retrosigmoid vestibular neurectomy for intractable vertigo in Ménière's disease: an interdisciplinary review. Acta Neurochir (Wien) 2008;150:655-661.
Godlowski Z. Pathogenesis and management of Ménière's syndrome in terms of microcirculation. Pharmacologic decompression of the endolymphatic hydrops. Angiology 1965;16:644-650.
Friis M, Klauss O. A potential portal flow in the inner ear. Laryngoscope 2007;117:194-198.
Nadol JB, Adam JC, Kim JR. Degenerative changes in the organ of Corti and lateral cochlear wall in experimental endolymphatic hydrops and human Meniere's disease. Acta Otolaryngol Suppl 1995:519:47-59.
Ichimiya I, Adams JC, Kimura RS. Changes in immunostaining of cochleas with experimentally induced endolymphatic hydrops. Ann Otol Rhinol Laryngol 1994;103:457-468.
Friberg U, Rask-Andersen H. Vascular occlusion in the endolymphatic sac in Meniere's disease. Ann Otol Rhinol Laryngol 2002;11(3 pt 1):237-245.
Barbara M, Monini S, Chiappini I, Ronchetti F, Raffa S, Torrisi MR. Perisaccular vascular obstruction during an acute attack of Meniere's disease. Mediterr J Otol 2007;3:40-46.
Zamboni P. The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med 2006;99:589-593.
Lee BB, Bergan J, Gloviczki, et al. Diagnosis and treatment of venous malformations Consensus Document of the International Union of Phlebology (IUP)-2009. Int Angiol 2009;28:434-451.
Lee BB, Baumgartner I, Berlien P, et al. Diagnosis and treatment of venous malformations. consensus document of the International Union of Phlebology (IUP): updated 2013. Int Angiol 2015;34:97-149.
Zamboni P, Galeotti R, Menegatti E, et al. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg 2009;50:1348-1358.
Merchant SN, Adams JC, Nadol JB Jr. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 2005;26:74-81.
Alpini DC, Bavera PM, Hahn A, Mattei V. Chronic cerebrospinal venous insufficiency (CCSVI) in Meniere disease. Case or Cause? ScienceMED 2013;4:9-15.
Filipo R, Ciciariello F, Attanasio G, et al. Chronic cerebrospinal venous insufficiency in patients with Meniere's disease. Eur Arch Othorinolaringol 2013;272:77-82.
Bruno A, Califano l, Mastrangelo D, et al. Chronic cerebrospinal venous insufficiency in Menière disease: diagnosis and treatment. Otorinolaringologia 2013;63:173.
Di Berardino F, Alpini DC, Bavera PM, et al. Chronic cerebrospinal venous insufficiency in Ménière disease. Phlebology 2015;30:274-279.
Bruno A, Califano L, Mastrangelo D, De Vizia M., Bernardo B, Salafia F. Chronic cerebrospinal venous insufficiency in Meniere's disease: diagnosis and treatment. Veins Lymphatics 2014;3:77-80.
Bruno A, Napolitano M, Califano L, et al. The prevalence of chronic cerebrospinal venous insufficiency in Meniere disease: 24-month follow-up after angioplasty. J Vasc Interv Radiol 2017;28:388-391.
Monzani D, Genovese E, Marraral A, et al. Validity of the Italian adaptation of the Tinnitus Handicap Inventory; focus on quality of life and psychological distress in tinnitus-sufferers. Acta Otorhinolaryngol Ital 2008;28:126-134.
Nola G, Mostardini C, Salvi V, Ercolani AP, Ralli G. Validity of Italian adaptation of the Dizziness Handicap Inventory (DHI) and evaluation of the quality of life in patients with acute dizziness. Acta Otorhinolaryngol Ital 2010;30:190-197.
Zivadinov R, Bastianello S, Dake MD, et al. Recommendations for multimodal noninvasive and invasive screening for detection of extracranial venous abnormalities indicative of chronic cerebrospinal venous insufficiency: a position statement of the International Society for Neurovascular Disease. J Vasc Interv Radiol 2014;25:1785-1794
Ciccone MM, Galeandro AI, Scicchitano P, et al. Multigate quality Doppler profiles and morphological/hemodynamic alterations in multiple sclerosis patients. Curr Neurovasc Res 2012;9:120-127.
Mazzoni A. Vein of the vestibular aqueduct. Ann Otol Rhinol Laryngol 1979;88:759-767.
Nakai Y, Masutani H, Moriguchi M, Matsunaga K, Kato A, Maeda H. Microvasculature of normal and hydropic labyrinth. Scanning Microsc 1992;6:1097-1103.
Sisini F, Toro E, Gambaccini M, Zamboni P. The oscillating component of the internal jugular vein flow: the overlooked element of cerebral circulation. Behav Neurol 2015;2015:170756.
Adrion C, Fischer CS, Wagner J, Gürkov R, Mansmann U, Strupp M; BEMED study group. Efficacy and safety of betahistine treatment in patients with Meniere's disease: multicentre, double blind, randomized, placebo controlled, dose defining trial (BEMED trial). BMJ 2016;352:h6816.
Giaquinta A, Beggs CB, Veroux M, et al. Factors influencing the hemodynamic response to balloon angioplasty in the treatment of outflow anomalies of internal jugular veins. J Vasc Surg Venous Lymphat Disord 2017;5:777-788.